RecallHawk

ACTHAR (REPOSITORY CORTICOTROPIN)

MALLINCKRODT IRELAND

Summary

FDA approved ACTHAR (REPOSITORY CORTICOTROPIN) by MALLINCKRODT IRELAND. NDA (New Drug) approval (Labeling) on 2024-02-29. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

NDA008372-74

Action Date

2024-02-29

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

ACTHAR (generic: REPOSITORY CORTICOTROPIN), INJECTABLE, INJECTION. Application: NDA008372

Context & Analysis

MALLINCKRODT IRELAND has 2 FDA actions in our database.

Frequently Asked Questions

How often does MALLINCKRODT IRELAND have FDA actions?

MALLINCKRODT IRELAND has 2 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA008372-74" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions